PSCR (Proto Script Pharmaceutical) EBIT per Share: $-0.01 (TTM As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical EBIT per Share?

Proto Script Pharmaceutical PSCR EBIT per Share is $-0.01 as of Sep. 2017.

Proto Script Pharmaceutical's EBIT per Share for the three months ended in Sep. 2017 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2017 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Proto Script Pharmaceutical's EBIT per Share or its related term are showing as below:

PSCR's 3-Year EBIT Growth Rate is not ranked *
in the Business Services industry.
Industry Median: 8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Proto Script Pharmaceutical's EBIT for the three months ended in Sep. 2017 was $-0.17 Mil.

Proto Script Pharmaceutical  (OTCPK:PSCR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Proto Script Pharmaceutical EBIT per Share Related Terms

Proto Script Pharmaceutical EBIT per Share Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical EBIT per Share Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
EBIT per Share
-0.00 -0.00 -0.00 -0.00 -0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00

Proto Script Pharmaceutical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Proto Script Pharmaceutical's EBIT per Share for the fiscal year that ended in May. 2016 is calculated as

EBIT per Share(A: May. 2016 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.033/30.480
=-0.00

Proto Script Pharmaceutical's EBIT per Share for the quarter that ended in Sep. 2017 is calculated as

EBIT per Share(Q: Sep. 2017 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.166/49.140
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
Proto Script Pharmaceutical (PSCR) has a EBIT per Share of $-0.01 as of Sep. 2017. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's EBIT per Share too high?
Proto Script Pharmaceutical's current EBIT per Share is $-0.01.
How does Proto Script Pharmaceutical's EBIT per Share compare to EXCC and NXES?
Proto Script Pharmaceutical's EBIT per Share of $-0.01 can be compared against companies in the Business Services industry. The industry median EBIT per Share is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Business Services company?
The median EBIT per Share among Business Services companies is 8.00, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Proto Script Pharmaceutical and its competitors. For the Business Services industry, the median EBIT per Share is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current EBIT per Share is $-0.01 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.